Status:
COMPLETED
Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
BioFire Diagnostics, LLC
Conditions:
Bacteremia
Sepsis
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the clinical impact of a rapid multiplex PCR blood culture identification panel on time to optimal antimicrobial therapy when compared to conventional microbiolo...
Detailed Description
A retrospective review of positive blood cultures was performed on pediatric patients at a tertiary hospital in Guatemala City. These will serve as retrospective controls. The prospective portion of t...
Eligibility Criteria
Inclusion
- Age \<18 years of age
- First positive blood culture during the hospitalization
Exclusion
- Non-blood specimens
- Repeat positive blood cultures from the same admission
- Patients who expire prior to positive culture
- Outpatient blood cultures
Key Trial Info
Start Date :
April 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2022
Estimated Enrollment :
479 Patients enrolled
Trial Details
Trial ID
NCT05314816
Start Date
April 7 2022
End Date
November 28 2022
Last Update
June 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Roosevelt
Guatemala City, Guatemala